Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer
Clinical trial NCT04447092 · UNKNOWN
Trial details
- NCT number
- NCT04447092
- Sponsor
- Seoul National University Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2024-12-31
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.